Proehl Investment Ventures LLC - 17 Aug 2021 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Reporting relationship: 10%+ Owner
Issuer ticker: DRMA
Reported as of: 17 Aug 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Aug 2021, 12:48:25 UTC
Prior SEC filing: 12 Aug 2021
Source filing: View source filing
Reporting owner signature: /s/ Gerald T. Proehl, Managing Member

Key filing fact

Proehl Investment Ventures LLC filed Form 4 for Dermata Therapeutics, Inc. (DRMA) on 17 Aug 2021.

Key facts

This page summarizes Proehl Investment Ventures LLC's Form 4 filing for Dermata Therapeutics, Inc. (DRMA).
12 reported transactions and 7 derivative rows are listed below.
Accepted by SEC: 17 Aug 2021, 12:48.

Change

Previous filing in this sequence was filed on 12 Aug 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DRMA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +361,147
Change %: +39%
Price
Shares after: 1,278,464
Date: 17 Aug 2021
Ownership: Direct
Footnotes: F1

DRMA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +111,951
Change %: +8.8%
Price
Shares after: 1,390,415
Date: 17 Aug 2021
Ownership: Direct
Footnotes: F2

DRMA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +181,585
Change %: +13%
Price
Shares after: 1,572,000
Date: 17 Aug 2021
Ownership: Direct
Footnotes: F3

DRMA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +1,247,904
Change %: +79%
Price
Shares after: 2,819,904
Date: 17 Aug 2021
Ownership: Direct
Footnotes: F4

DRMA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +85,640
Change %: +3%
Price
Shares after: 2,905,544
Date: 17 Aug 2021
Ownership: Direct
Footnotes: F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DRMA transaction Derivative

Series 1d Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -2,436,657
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 17 Aug 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 361,147
Exercise price
Footnotes: F1

DRMA transaction Derivative

Series 1a Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -2,295,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 17 Aug 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 111,951
Exercise price
Footnotes: F2

DRMA transaction Derivative

Series 1b Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -3,722,500
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 17 Aug 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 181,585
Exercise price
Footnotes: F3

DRMA transaction Derivative

Series 1c Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -25,582,050
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 17 Aug 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,247,904
Exercise price
Footnotes: F4

DRMA transaction Derivative

Series 1 Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -1,755,622
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 17 Aug 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 85,640
Exercise price
Footnotes: F5

DRMA transaction Derivative

Series 1a Warrants

Conversion of derivative security

Transaction value: $0
Shares: -573,750
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 17 Aug 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 27,987
Exercise price
Footnotes: F6

DRMA transaction Derivative

Warrant to Purchase Common Stock

Conversion of derivative security

Transaction value: $0
Shares: +27,987
Change %
Price: $0.000000
Shares after: 27,987
Date: 17 Aug 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 27,987
Exercise price: $20.50

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date.

Footnote F2

The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date.

Footnote F3

The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date.

Footnote F4

The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date.

Footnote F5

The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date.

Footnote F6

The Series 1a Preferred Warrants converted into warrants to purchase Common Stock in connection with the IPO.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .